Uroplasty, Inc. (AMEX: UPI), a global medical device company, is focused on developing, manufacturing, and marketing products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders. The company offers a wide range of products that meet the demands of healthcare professionals and patients. Their devices help healthcare professionals increase the efficiency of their treatment options while reducing patient risk. For further information, visit the Company’s web site at www.uroplasty.com.
- 17 years ago
QualityStocks
Uroplasty, Inc. (AMEX: UPI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – GlobalTech Corp. (GLTK) Advancing AI and Data Solutions with Diversified Portfolio
GlobalTech (OTC: GLTK) is a diversified technology holding company focused on AI, big data, and digital…
-
QualityStocksNewsBreaks – SuperCom Ltd.’s (NASDAQ: SPCB) PureSecurity(TM) Suite Sets New Standard Through Key Contract Win
SuperCom (NASDAQ: SPCB) has secured a national electronic monitoring contract in Germany valued at up to…
-
QualityStocksNewsBreaks – BluSky AI Inc.’s (BSAI) Modular Neocloud Platform Set to Power AI Era
BluSky AI (OTC: BSAI) is emerging as a key player in the rapidly growing neocloud market—a…